Cart
sales@molnova.com
PKG drug G1
CAS No. 374703-78-3
PKG drug G1 ( —— )
Catalog No. M18488 CAS No. 374703-78-3
PKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 46 | In Stock |
|
| 5MG | 72 | In Stock |
|
| 10MG | 110 | In Stock |
|
| 25MG | 177 | In Stock |
|
| 50MG | 335 | In Stock |
|
| 100MG | 500 | In Stock |
|
| 500MG | 1098 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NamePKG drug G1
-
NoteResearch use only, not for human use.
-
Brief DescriptionPKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
-
DescriptionPKG drug G1 targets C42 of PKG Iα. PKG drug G1 can couple to vasodilation and blood pressure lowering by a C42 PKG Iα-independent mechanism.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorPKG Iα
-
Research AreaCardiovascular Disease
-
Indication——
Chemical Information
-
CAS Number374703-78-3
-
Formula Weight257.31
-
Molecular FormulaC13H11N3OS
-
Purity98%
-
SolubilityDMSO : ≥ 103 mg/mL; 400.30 mM
-
SMILESS=C3N/C(=C\c1c(C)nc2ccccc12)C(=O)N3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Burgoyne JR, et al. Proof of Principle for a Novel Class of Antihypertensives That Target the Oxidative Activation of PKG Iα (Protein Kinase G Iα). Hypertension. 2017 Sep;70(3):577-586.
molnova catalog
related products
-
Kojibiose
Kojibiose is a disaccharide in honey. Kojibiose is a product of the caramelization of glucose.
-
PAMBA
4-(Aminomethyl)benzoic acid is an unnatural amino acid derivative, is an antifibrinolytic.
-
Dacisteine
Dacisteine is an inhibitor of New Delhi metallo-beta-lactamase-1 (NDM-1, IC50 = 1000 μM).
